Definitive Contract 75A50124C00045
Award Date
9/23/24
Potential Completion Date
4/30/26
Potential Value
$734K
Awardee
Thrixen Pte. LTD.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Singapore
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a sole-source federal contract award to OraSure Technologies, Inc., a for-profit manufacturer of diagnostic medical testing products, to develop improvements to the OraQuick Ebola Rapid Antigen Test. The objective is to increase the test's sensitivity and shelf life, develop sustainable reagents to eliminate reliance on limited supplies, transition manufacturing to an automated line to improve quality and production speed, and purchase two lots of approximately 10,000 improved tests...
This is a $293,443,870.00 definitive contract awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) to Mapp Biopharmaceutical, Inc., a San Diego-based biotechnology company. The contract is for the provision of therapeutic interventions and medical countermeasures against infectious diseases and biothreats, including viral hemorrhagic fevers like Ebola, Marburg, and Lassa, as well as botulinum neurotoxin. Mapp...
The U.S. Department of Health and Human Services (HHS) awarded a $240,491.71 firm-fixed-price purchase order to OraSure Technologies Inc. (doing business as OraSure) for the acquisition of Filovirus Point-of-Care (POC) diagnostic tests. The award, which has no set-aside designation, supports the procurement of a minimum of 8,500 lateral flow, rapid antigen tests for Ebola virus that can be used on oral fluids from cadavers and have a nine-month shelf life. OraSure is the only current provider...
This is a $212,905.91 firm-fixed-price definitive contract awarded by the U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response to Satio Inc., a for-profit manufacturer based in Boston, Massachusetts. The contract is for research and development related to the development of a low-cost, integrated, lateral flow immunoassay and blood collection diagnostic for Ebolavirus, under Area of Interest #20. The contract has a period of performance...
This is a federal contract award to Orasure Technologies Inc., a for-profit manufacturer of diagnostic medical testing products, to modify the OraQuick test platform to enable antigen detection of the Ebola Zaire virus for use with various sample types. The purpose of this $11,937,826.99 cost-plus-fixed-fee contract modification is to transfer all government property associated with the original contract to a new contract. The contract is funded by the Office of the Assistant Secretary for...
This $2,306,148 federal contract was awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) to Battelle Memorial Institute to support an efficacy study of a monoclonal antibody (MAb) therapeutic against the Ebola virus (EBOV) lethal challenge in rhesus macaques. The contract is a Delivery Order issued under Battelle's BARDA Biological Animal Model Development 2017-2022 Indefinite Delivery/Indefinite Quantity (IDIQ)...
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a division of the Department of Health and Human Services (HHS), to Alpha Diagnostic International Inc. The award, valued at $13,666.00, is for the procurement of an "AMBIS #1709226 HUMAN ANTI-ZAIRE-EBOLA VIRUS GLYCOPROTEIN (GP) IGG ELISA KIT". This is a firm fixed-price purchase order with a completion date of November 14, 2014. The contract does not have a set-aside designation.
This is a delivery order awarded by the Centers for Disease Control and Prevention (CDC) under the Safety and Healthcare Epidemiology Prevention Research Development (SHEPheRD) indefinite delivery, indefinite quantity (IDIQ) contract. The contract was awarded to Health Core, Inc., a for-profit organization, to provide services related to the Ebola virus response, as indicated by the solicitation number "RFTOP 2015-010 AUR EBOLA". The contract has a firm fixed price of $491,954.00 and a...
The Department of Health and Human Services (HHS), through the Office of the Assistant Secretary for Preparedness and Response (ASPR), awarded a $618,200 firm-fixed-price contract to Bugseq Bioinformatics Inc. for the development of scalable sequencing approaches to detect novel pathogens. This contract, which has a completion date of January 31, 2024, was awarded under ASPR-22-00799, a solicitation issued under the Easy Broad Agency Announcement (EZ-BAA) from the Division of Research,...
This is a federal contract awarded by the Defense Threat Reduction Agency (DTRA), a defense agency, to Mapp Biopharmaceutical, Inc., a biotechnology company specializing in the development of antibody-based therapeutics and medical countermeasures against infectious diseases and biothreats. The contract, valued at $6,173,324.00, is for research and development services during the base period, with a period of performance ending on August 31, 2017. The contract is a Cost Plus Fixed Fee Definitive...